Healthcare
Live Price
Offline$172.57
-3.32% today
1Y Change
+3.67%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tenet Healthcare Corporation (THC) is a Healthcare stock with a market cap of $16.06B and listed on NYSE. The stock last traded around $172.57 and up 3.7% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of +3.1%, EPS growth of -52.7%, a dividend yield of 0.0%. What stands out right now is revenue +3.1%, EPS -52.7%, free cash flow +126.7% with operating margin 16.1% and ROIC 11.5%. Valuation is more restrained than many high-expectation growth names at P/E 9.3 and price/sales 0.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines THC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THC Max Drawdown
-29.25%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for THC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$19.5B
+1.6% YoY
FY Net Income
$914.0M
+122.4% YoY
Free Cash Flow
$910.0M
+183.5% YoY
Revenue Growth
+3.1%
EPS Growth
-52.7%
Gross Margin
42.8%
Net Margin
7.9%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 21.3B | 20.7B | 20.5B | 19.2B | 19.5B |
| Gross Profit | 8.8B | 8.2B | 7.8B | 7.0B | 7.3B |
| Operating Income | 3.5B | 6.0B | 2.5B | 2.3B | 2.9B |
| EBITDA | 4.3B | 6.9B | 3.4B | 3.1B | 3.7B |
| Net Income | 1.4B | 3.2B | 611M | 411M | 914M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.9B | 3.0B | 1.2B | 858M | 2.4B |
| Total Assets | 29.7B | 28.9B | 28.3B | 27.2B | 27.6B |
| Total Liabilities | 20.7B | 20.4B | 22.8B | 22.5B | 23.3B |
| Shareholder Equity | 4.2B | 4.2B | 1.6B | 1.1B | 1.0B |
| Total Debt | 13.2B | 14.3B | 15.0B | 15.1B | 15.6B |
| Net Debt | 10.3B | 11.3B | 13.8B | 14.2B | 13.3B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.6B
+44.8% YoY
Capital Expenditures
658M
+13.6% YoY
Free Cash Flow
910M
+183.5% YoY
Key ratios
Gross Margin
42.8%
Operating Margin
16.1%
Net Margin
7.9%
ROE
40.6%
Debt / Equity
2.74x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.